Molecular profiles based on ctDNA sequencing inform treatment decisions for cancer patients in early phase clinical trials from Caroline Dive and colleagues CRUKMI httpgo.nature.com2GzP4FZÂpic.twitter.comyZo0fYUe5D

Molecular profiles based on #ctDNA sequencing inform treatment decisions for #cancer patients in early phase clinical trials, from Caroline Dive and colleagues @CRUK_MI | http://go.nature.com/2GzP4FZ pic.twitter.com/yZo0fYUe5D

14:01 EDT 1 May 2019 | Nature Publishing

Molecular profiles based on #ctDNA sequencing inform treatment decisions for #cancer patients in early phase clinical trials, from Caroline Dive and colleagues @CRUK_MI | http://go.nature.com/2GzP4FZ  pic.twitter.com/yZo0fYUe5D

More From BioPortfolio on "Molecular profiles based on #ctDNA sequencing inform treatment decisions for #cancer patients in early phase clinical trials, from Caroline Dive and colleagues @CRUK_MI | http://go.nature.com/2GzP4FZ pic.twitter.com/yZo0fYUe5D"